Morgan Stanley upgrades Bristol-Myers Squibb (NYSE: BMY) from Equalweight to Overweight. The firm also raises its price target on the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE